Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/6/2026 | 737 | 0.0% | 11,102 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 377 | 0.0% | 10,924 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 167 | 0.0% | 10,598 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 34 | 0.0% | 2,666 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 66 | 0.0% | 3,485 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 92 | 0.0% | 4,763 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 102 | 0.0% | 3,912 | 6/30/2024 |
| 2024 Q1 | 5/10/2024 | 78 | 0.0% | 2,735 | 3/31/2024 |
| 2023 Q4 | 3/22/2024 | 66 | 0.0% | 2,149 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 62 | 0.0% | 2,296 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 814 | 0.0% | 22,832 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 550 | 0.0% | 21,653 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 925 | 0.0% | 22,814 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 773 | 0.0% | 23,399 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 784 | 0.0% | 22,254 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 1,043 | 0.0% | 22,684 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 1,507 | 0.0% | 22,727 | 12/31/2021 |
| 2021 Q3 | 11/5/2021 | 1,392 | 0.0% | 22,295 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 1,876 | 0.0% | 22,649 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 1,499 | 0.0% | 22,614 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,724 | 0.0% | 22,458 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 925 | 0.0% | 21,495 | 9/30/2020 |
| 2020 Q2 | 8/28/2020 | 87 | 0.0% | 2,010 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 61 | 0.0% | 2,130 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 153 | 0.0% | 2,402 | 12/31/2019 |